Lanean...
Analysis of HIV‐1 mutation patterns in patients failing antiretroviral therapy
The emergence of mutations encoding drug resistance is supposed to be a significant limitation to the clinical efficacy of inhibitor compounds directed against specific HIV‐1 enzymatic targets. We have used a commercial test (Visible Genetics Inc., Paris, France) to study the prevalence of mutations...
Gorde:
| Argitaratua izan da: | J Clin Lab Anal |
|---|---|
| Egile Nagusiak: | , , , , , , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
John Wiley & Sons, Inc.
2001
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6807694/ https://ncbi.nlm.nih.gov/pubmed/11170234 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/1098-2825(2001)15:1<43::AID-JCLA9>3.0.CO;2-I |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|